These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9007144

  • 1. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
    Blum I, Vered Y, Lifshitz A, Harel D, Blum M, Nordenberg Y, Harsat A, Sulkes J, Gabbay U, Graff E.
    Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
    [Abstract] [Full Text] [Related]

  • 2. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
    Limpaphayom K, Taechakraichana N, Kittinunvorakoon C.
    J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
    [Abstract] [Full Text] [Related]

  • 3. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A, Zhang J, Ding L.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [Abstract] [Full Text] [Related]

  • 4. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J, Kooistra HS, Djajadiningrat-Laanen SC, Dieleman SJ, Okkens AC.
    Theriogenology; 2006 Apr 15; 65(7):1346-59. PubMed ID: 16197989
    [Abstract] [Full Text] [Related]

  • 5. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T, Sakuma K, Ikeda A, Ueki M.
    J Med; 2004 Apr 15; 35(1-6):281-94. PubMed ID: 18084886
    [Abstract] [Full Text] [Related]

  • 6. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
    Light KC, Grewen KM, Amico JA, Brownley KA, West SG, Hinderliter AL, Girdler SS.
    Horm Behav; 2005 May 15; 47(5):540-8. PubMed ID: 15811355
    [Abstract] [Full Text] [Related]

  • 7. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec 11; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 9. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF.
    Climacteric; 2007 Oct 11; 10(5):427-37. PubMed ID: 17852146
    [Abstract] [Full Text] [Related]

  • 10. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
    Ushiroyama T, Sakai M, Higashiyama T, Ikeda A, Ueki M.
    Gynecol Endocrinol; 2001 Feb 11; 15(1):74-80. PubMed ID: 11293929
    [Abstract] [Full Text] [Related]

  • 11. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.
    Menopause; 2008 Feb 11; 15(6):1060-4. PubMed ID: 18521047
    [Abstract] [Full Text] [Related]

  • 12. [Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
    Yasui T, Uemura H, Yoneda N, Irahara M, Aono T, Sunahara S, Hata K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul 11; 47(7):655-61. PubMed ID: 7636337
    [Abstract] [Full Text] [Related]

  • 13. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
    Håkan Wallén N, Li N, Eriksson-Berg M, Landgren BM, Schenck-Gustafsson K, Hjemdahl P.
    Thromb Haemost; 2006 Dec 11; 96(6):862-3. PubMed ID: 17139389
    [No Abstract] [Full Text] [Related]

  • 14. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 15. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol.
    Carretti N, Florio P, Reis FM, Comai S, Petraglia F, Costa CV.
    Climacteric; 2007 Oct 10; 10(5):393-9. PubMed ID: 17852142
    [Abstract] [Full Text] [Related]

  • 16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 10; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 17. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC, Napoli N, Klug T, Civitelli R.
    Bone; 2004 Sep 10; 35(3):682-8. PubMed ID: 15336604
    [Abstract] [Full Text] [Related]

  • 18. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
    Carr BR, Khan N, Adams-Huet B, Kakarla N, Havelock JC, Gell J.
    Fertil Steril; 2006 Mar 10; 85(3):667-73. PubMed ID: 16500336
    [Abstract] [Full Text] [Related]

  • 19. Effects of estrogen-progestin replacement therapy on plasma beta-endorphin levels in menopausal women.
    Ortega E, Cuadros JL, Gonzalez AR, Ruiz E.
    Biochem Mol Biol Int; 1993 Apr 10; 29(5):831-6. PubMed ID: 8508135
    [Abstract] [Full Text] [Related]

  • 20. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
    Kawai H, Furuhashi M, Suganuma N.
    Arch Gynecol Obstet; 2004 Mar 10; 269(3):192-5. PubMed ID: 13680264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.